Rare diseases have become an attractive target for pharmaceutical companies both on the ASX and internationally.

Operator Good day, ladies and gentlemen, and welcome to the Exelixis fourth quarter and fiscal year 2024 financial results ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Request To Download Free Sample of This Strategic Report@ Highlighted with 148 tables and 111 figures, this 241-page report ?Global Clinical Trials Market 2022-2031 by Product Category (Drugs, ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 99 tables and 79 figures, this 186-page report ?Europe Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

The Alzheimer’s Association hailed the development ... A six-month course would cost $12,522 while the drug would cost $48,696 for patients who need to stay on it for 18 months.

Each step is crucial and can be costly, but the ultimate gains of an ECA far outweigh these costs. "Evidence generation in drug development ... medicine stage to phase 2A seldom are submitted ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in a related lung disease leading the drugmaker to expand the indications ...

To find out the cost of Wakix for you, talk with your doctor, pharmacist, or insurance provider. Wakix only comes as a brand-name drug. It’s not currently available in a generic version.